Increasing access to specialty care: A pilot, randomized controlled trial of telemedicine for Parkinson's disease
We conducted a randomized, controlled pilot trial to evaluate the feasibility of providing subspecialty care via telemedicine for patients with Parkinson's disease residing in a remote community located ∼130 miles from an academic movement disorders clinic. Study participants were randomized to...
Saved in:
| Published in | Movement disorders Vol. 25; no. 11; pp. 1652 - 1659 |
|---|---|
| Main Authors | , , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
15.08.2010
Wiley |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | We conducted a randomized, controlled pilot trial to evaluate the feasibility of providing subspecialty care via telemedicine for patients with Parkinson's disease residing in a remote community located ∼130 miles from an academic movement disorders clinic. Study participants were randomized to receive telemedicine care with a movement disorder specialist at the University of Rochester or to receive their usual care. Participants in the telemedicine group received three telemedicine visits over six months. Feasibility, as measured by the completion of telemedicine visits, was the primary outcome measure. Secondary measures were quality of life, patient satisfaction, and clinical outcomes. Ten participants residing in the community were randomized to receive telemedicine care (n = 6) or their usual care (n = 4). Four nursing home patients were assigned to telemedicine. Those receiving telemedicine completed 97% (29 of 30) of their telemedicine visits as scheduled. At the study's conclusion, 13 of 14 study participants opted to receive specialty care via telemedicine. Compared with usual care, those randomized to telemedicine had significant improvements in quality of life (3.4 point improvement vs. 10.3 point worsening on the Parkinson's Disease Questionnaire 39; P = 0.04) and motor performance (0.3 point improvement vs. 6.5 point worsening on the Unified Parkinson's Disease Rating Scale, motor subscale; P = 0.03). Relative to baseline, nursing home patients experienced trends toward improvement in quality of life and patient satisfaction. Providing subspecialty care via telemedicine for individuals with Parkinson's disease living remotely is feasible. © 2010 Movement Disorder Society |
|---|---|
| AbstractList | We conducted a randomized, controlled pilot trial to evaluate the feasibility of providing subspecialty care via telemedicine for patients with Parkinson's disease residing in a remote community located ∼130 miles from an academic movement disorders clinic. Study participants were randomized to receive telemedicine care with a movement disorder specialist at the University of Rochester or to receive their usual care. Participants in the telemedicine group received three telemedicine visits over six months. Feasibility, as measured by the completion of telemedicine visits, was the primary outcome measure. Secondary measures were quality of life, patient satisfaction, and clinical outcomes. Ten participants residing in the community were randomized to receive telemedicine care (n = 6) or their usual care (n = 4). Four nursing home patients were assigned to telemedicine. Those receiving telemedicine completed 97% (29 of 30) of their telemedicine visits as scheduled. At the study's conclusion, 13 of 14 study participants opted to receive specialty care via telemedicine. Compared with usual care, those randomized to telemedicine had significant improvements in quality of life (3.4 point improvement vs. 10.3 point worsening on the Parkinson's Disease Questionnaire 39; P = 0.04) and motor performance (0.3 point improvement vs. 6.5 point worsening on the Unified Parkinson's Disease Rating Scale, motor subscale; P = 0.03). Relative to baseline, nursing home patients experienced trends toward improvement in quality of life and patient satisfaction. Providing subspecialty care via telemedicine for individuals with Parkinson's disease living remotely is feasible. © 2010 Movement Disorder Society We conducted a randomized, controlled pilot trial to evaluate the feasibility of providing subspecialty care via telemedicine for patients with Parkinson's disease residing in a remote community located approximately 130 miles from an academic movement disorders clinic. Study participants were randomized to receive telemedicine care with a movement disorder specialist at the University of Rochester or to receive their usual care. Participants in the telemedicine group received three telemedicine visits over six months. Feasibility, as measured by the completion of telemedicine visits, was the primary outcome measure. Secondary measures were quality of life, patient satisfaction, and clinical outcomes. Ten participants residing in the community were randomized to receive telemedicine care (n = 6) or their usual care (n = 4). Four nursing home patients were assigned to telemedicine. Those receiving telemedicine completed 97% (29 of 30) of their telemedicine visits as scheduled. At the study's conclusion, 13 of 14 study participants opted to receive specialty care via telemedicine. Compared with usual care, those randomized to telemedicine had significant improvements in quality of life (3.4 point improvement vs. 10.3 point worsening on the Parkinson's Disease Questionnaire 39; P = 0.04) and motor performance (0.3 point improvement vs. 6.5 point worsening on the Unified Parkinson's Disease Rating Scale, motor subscale; P = 0.03). Relative to baseline, nursing home patients experienced trends toward improvement in quality of life and patient satisfaction. Providing subspecialty care via telemedicine for individuals with Parkinson's disease living remotely is feasible. We conducted a randomized, controlled pilot trial to evaluate the feasibility of providing subspecialty care via telemedicine for patients with Parkinson's disease residing in a remote community located approximately 130 miles from an academic movement disorders clinic. Study participants were randomized to receive telemedicine care with a movement disorder specialist at the University of Rochester or to receive their usual care. Participants in the telemedicine group received three telemedicine visits over six months. Feasibility, as measured by the completion of telemedicine visits, was the primary outcome measure. Secondary measures were quality of life, patient satisfaction, and clinical outcomes. Ten participants residing in the community were randomized to receive telemedicine care (n = 6) or their usual care (n = 4). Four nursing home patients were assigned to telemedicine. Those receiving telemedicine completed 97% (29 of 30) of their telemedicine visits as scheduled. At the study's conclusion, 13 of 14 study participants opted to receive specialty care via telemedicine. Compared with usual care, those randomized to telemedicine had significant improvements in quality of life (3.4 point improvement vs. 10.3 point worsening on the Parkinson's Disease Questionnaire 39; P = 0.04) and motor performance (0.3 point improvement vs. 6.5 point worsening on the Unified Parkinson's Disease Rating Scale, motor subscale; P = 0.03). Relative to baseline, nursing home patients experienced trends toward improvement in quality of life and patient satisfaction. Providing subspecialty care via telemedicine for individuals with Parkinson's disease living remotely is feasible.We conducted a randomized, controlled pilot trial to evaluate the feasibility of providing subspecialty care via telemedicine for patients with Parkinson's disease residing in a remote community located approximately 130 miles from an academic movement disorders clinic. Study participants were randomized to receive telemedicine care with a movement disorder specialist at the University of Rochester or to receive their usual care. Participants in the telemedicine group received three telemedicine visits over six months. Feasibility, as measured by the completion of telemedicine visits, was the primary outcome measure. Secondary measures were quality of life, patient satisfaction, and clinical outcomes. Ten participants residing in the community were randomized to receive telemedicine care (n = 6) or their usual care (n = 4). Four nursing home patients were assigned to telemedicine. Those receiving telemedicine completed 97% (29 of 30) of their telemedicine visits as scheduled. At the study's conclusion, 13 of 14 study participants opted to receive specialty care via telemedicine. Compared with usual care, those randomized to telemedicine had significant improvements in quality of life (3.4 point improvement vs. 10.3 point worsening on the Parkinson's Disease Questionnaire 39; P = 0.04) and motor performance (0.3 point improvement vs. 6.5 point worsening on the Unified Parkinson's Disease Rating Scale, motor subscale; P = 0.03). Relative to baseline, nursing home patients experienced trends toward improvement in quality of life and patient satisfaction. Providing subspecialty care via telemedicine for individuals with Parkinson's disease living remotely is feasible. We conducted a randomized, controlled pilot trial to evaluate the feasibility of providing subspecialty care via telemedicine for patients with Parkinson's disease residing in a remote community located ∼130 miles from an academic movement disorders clinic. Study participants were randomized to receive telemedicine care with a movement disorder specialist at the University of Rochester or to receive their usual care. Participants in the telemedicine group received three telemedicine visits over six months. Feasibility, as measured by the completion of telemedicine visits, was the primary outcome measure. Secondary measures were quality of life, patient satisfaction, and clinical outcomes. Ten participants residing in the community were randomized to receive telemedicine care (n = 6) or their usual care (n = 4). Four nursing home patients were assigned to telemedicine. Those receiving telemedicine completed 97% (29 of 30) of their telemedicine visits as scheduled. At the study's conclusion, 13 of 14 study participants opted to receive specialty care via telemedicine. Compared with usual care, those randomized to telemedicine had significant improvements in quality of life (3.4 point improvement vs. 10.3 point worsening on the Parkinson's Disease Questionnaire 39; P = 0.04) and motor performance (0.3 point improvement vs. 6.5 point worsening on the Unified Parkinson's Disease Rating Scale, motor subscale; P = 0.03). Relative to baseline, nursing home patients experienced trends toward improvement in quality of life and patient satisfaction. Providing subspecialty care via telemedicine for individuals with Parkinson's disease living remotely is feasible. © 2010 Movement Disorder Society |
| Author | Eason, Sheelah George, Benjamin P. Joseph, Anthony Reminick, Jason I. Miller, David Viti, Lucy Biglan, Kevin M. Polanowicz, Joyce Voss, Tiffini S. Appler, Anna Dorsey, E. Ray Deuel, Lisa M. Finnigan, Kara Smith, Sandy |
| Author_xml | – sequence: 1 givenname: E. Ray surname: Dorsey fullname: Dorsey, E. Ray email: ray.dorsey@ctcc.rochester.edu organization: Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA – sequence: 2 givenname: Lisa M. surname: Deuel fullname: Deuel, Lisa M. organization: Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA – sequence: 3 givenname: Tiffini S. surname: Voss fullname: Voss, Tiffini S. organization: Department of Neurology, University of Virginia Health System, Charlottesville, Virginia, USA – sequence: 4 givenname: Kara surname: Finnigan fullname: Finnigan, Kara organization: Warner School of Education, University of Rochester, Rochester, New York, USA – sequence: 5 givenname: Benjamin P. surname: George fullname: George, Benjamin P. organization: School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA – sequence: 6 givenname: Sheelah surname: Eason fullname: Eason, Sheelah organization: Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA – sequence: 7 givenname: David surname: Miller fullname: Miller, David organization: Clinical Trials Coordination Center, University of Rochester Medical Center, Rochester, New York, USA – sequence: 8 givenname: Jason I. surname: Reminick fullname: Reminick, Jason I. organization: School of Medicine and Dentistry, University of Rochester, Rochester, New York, USA – sequence: 9 givenname: Anna surname: Appler fullname: Appler, Anna organization: Presbyterian Homes and Services, Inc., New Hartford, New York, USA – sequence: 10 givenname: Joyce surname: Polanowicz fullname: Polanowicz, Joyce organization: Presbyterian Homes and Services, Inc., New Hartford, New York, USA – sequence: 11 givenname: Lucy surname: Viti fullname: Viti, Lucy organization: Presbyterian Homes and Services, Inc., New Hartford, New York, USA – sequence: 12 givenname: Sandy surname: Smith fullname: Smith, Sandy organization: Presbyterian Homes and Services, Inc., New Hartford, New York, USA – sequence: 13 givenname: Anthony surname: Joseph fullname: Joseph, Anthony organization: Presbyterian Homes and Services, Inc., New Hartford, New York, USA – sequence: 14 givenname: Kevin M. surname: Biglan fullname: Biglan, Kevin M. organization: Department of Neurology, University of Rochester Medical Center, Rochester, New York, USA |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23164119$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/20533449$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc1uEzEUhS1URNPCghdA3qAKiWn9Px52VQulqAEk_paW47GRwWOntiMIT49DEpAQrHwX33d8dc8ROIgpWgAeYnSKESJn01hOCcWM3wEzzCnuJOH9AZghKXlHseSH4KiULwhhzLG4Bw4J4pQyNszA7XU02eri42eojbGlwJpgWVrjdahraHS2z-A5XPqQ6lOYdRzT5H_YEZoUa04htLHmBsPkYLXBTnb0xkcLXcrwrc5ffSwpnhQ4-tI-svfBXadDsQ927zH48OL5-4uX3c2bq-uL85vOMN7WHrjoLaELbjBjhjlGuBDODXKkBGOJiUBulAa7cVgwOfQLYakUTiJm-EJoQ4_ByTZ3mdPtypaqJl-MDUFHm1ZF9c0aWmrfyEc7crVo26tl9pPOa7W_UgMe7wBdjA6uXcH48oejWDCMN9zZljM5lZKtU8ZXXf3mUtoHhZHa9KVaX-pXX8148pexD_0Xu0v_5oNd_x9U88t3e6PbGr5U-_230TpRoqc9V59eXylBXtE5-Xip5vQnQ86y7g |
| CitedBy_id | crossref_primary_10_1089_tmj_2020_0419 crossref_primary_10_1093_heapol_czt078 crossref_primary_10_1080_21548331_2016_1166922 crossref_primary_10_3389_fneur_2015_00034 crossref_primary_10_3389_fneur_2020_573576 crossref_primary_10_1177_0891988713481269 crossref_primary_10_1002_14651858_CD002098_pub2 crossref_primary_10_3390_bs12110447 crossref_primary_10_1089_tmj_2015_0112 crossref_primary_10_3233_JPD_202402 crossref_primary_10_1089_tmj_2015_0191 crossref_primary_10_1002_mds_29129 crossref_primary_10_1007_s11136_013_0458_x crossref_primary_10_3233_JPD_202121 crossref_primary_10_1016_j_ibmed_2021_100046 crossref_primary_10_3233_JPD_240137 crossref_primary_10_1186_1745_6215_15_465 crossref_primary_10_1089_tmj_2021_0096 crossref_primary_10_1177_1357633X18792805 crossref_primary_10_1002_mdc3_13373 crossref_primary_10_1002_mdc3_13494 crossref_primary_10_1016_j_pmrj_2017_02_013 crossref_primary_10_3233_JPD_161048 crossref_primary_10_1002_pmrj_12001 crossref_primary_10_3390_brainsci11020237 crossref_primary_10_3233_JPD_202411 crossref_primary_10_3233_JPD_202019 crossref_primary_10_3233_JPD_223215 crossref_primary_10_14802_jmd_20042 crossref_primary_10_2196_31690 crossref_primary_10_1016_j_jamda_2016_02_004 crossref_primary_10_1212_WNL_0000000000004366 crossref_primary_10_1044_2022_AJSLP_22_00063 crossref_primary_10_1089_tmj_2011_0276 crossref_primary_10_1111_jgs_12027 crossref_primary_10_1038_s41746_019_0214_x crossref_primary_10_1186_s13063_015_0984_7 crossref_primary_10_1007_s41347_022_00261_7 crossref_primary_10_1155_2015_639494 crossref_primary_10_1177_0891988711422529 crossref_primary_10_1212_CPJ_0000000000000371 crossref_primary_10_1007_s11910_018_0834_6 crossref_primary_10_1016_j_jamda_2013_10_007 crossref_primary_10_1016_j_prdoa_2023_100188 crossref_primary_10_1097_FCH_0000000000000159 crossref_primary_10_1212_CPJ_0000000000000252 crossref_primary_10_1212_CPJ_0000000000001065 crossref_primary_10_1007_s13670_020_00311_z crossref_primary_10_1002_mds_25903 crossref_primary_10_1016_j_parkreldis_2015_02_018 crossref_primary_10_1177_1357633X15572201 crossref_primary_10_1007_s42451_022_00459_2 crossref_primary_10_1590_0004_282x20200131 crossref_primary_10_1212_CPJ_0000000000000259 crossref_primary_10_1155_2019_9403295 crossref_primary_10_1007_s13760_021_01732_z crossref_primary_10_1177_1460458214556373 crossref_primary_10_1002_mds_28293 crossref_primary_10_1038_s41531_021_00162_1 crossref_primary_10_1177_1357633X15571649 crossref_primary_10_1136_bmjno_2021_000173 crossref_primary_10_1212_WNL_0000000000004357 crossref_primary_10_1258_jtt_2012_SFT105 crossref_primary_10_1177_1460458217712054 crossref_primary_10_1212_NXG_0000000000200008 crossref_primary_10_3389_fpubh_2023_1150455 crossref_primary_10_1186_s12911_020_01155_5 crossref_primary_10_1186_s40734_019_0077_y crossref_primary_10_3390_medicina60060958 crossref_primary_10_14802_jmd_23130 crossref_primary_10_3399_BJGPO_2022_0073 crossref_primary_10_1177_2374373521997224 crossref_primary_10_1089_tmj_2017_0295 crossref_primary_10_1212_WNL_0b013e3182a823e0 crossref_primary_10_1136_bmjopen_2020_048293 crossref_primary_10_1080_20479700_2020_1870367 crossref_primary_10_1093_pubmed_fdad258 crossref_primary_10_1111_j_1468_1331_2011_03532_x crossref_primary_10_1186_s12984_020_00684_4 crossref_primary_10_14245_ns_2040684_342 crossref_primary_10_5665_sleep_5514 crossref_primary_10_1111_ane_13429 crossref_primary_10_1002_mds_25121 crossref_primary_10_1177_0733464816651884 crossref_primary_10_1212_WNL_0000000000008708 crossref_primary_10_1055_s_0042_1755323 crossref_primary_10_1159_000475801 crossref_primary_10_1038_ajg_2011_329 crossref_primary_10_1038_s43856_023_00246_4 crossref_primary_10_1016_j_pec_2015_11_005 crossref_primary_10_3233_JPD_181557 crossref_primary_10_1016_S1474_4422_17_30167_9 crossref_primary_10_1016_j_cct_2021_106632 crossref_primary_10_1016_j_prdoa_2021_100107 crossref_primary_10_1177_1357633X13483256 crossref_primary_10_1097_NCM_0000000000000371 crossref_primary_10_3109_21678421_2015_1069851 crossref_primary_10_3390_jcm13010299 crossref_primary_10_1212_WNL_0b013e3182377e29 crossref_primary_10_1287_serv_2018_0222 crossref_primary_10_3390_brainsci12010062 crossref_primary_10_3390_ijerph17030987 crossref_primary_10_1177_13872877241298295 crossref_primary_10_3389_fneur_2021_627999 crossref_primary_10_1155_2016_4802570 crossref_primary_10_1155_2021_5534282 crossref_primary_10_1177_1357633X221146819 crossref_primary_10_1111_jgs_13909 crossref_primary_10_1258_jtt_2012_120105 crossref_primary_10_1089_tmj_2017_0076 crossref_primary_10_1038_nrneurol_2018_31 crossref_primary_10_3233_JPD_202109 crossref_primary_10_1007_s00415_011_5920_5 crossref_primary_10_1177_1357633X17752030 crossref_primary_10_1016_j_parkreldis_2012_10_008 crossref_primary_10_1016_j_parkreldis_2013_04_022 crossref_primary_10_1177_2055207615592998 crossref_primary_10_1097_01_NT_0000434613_64423_c6 crossref_primary_10_1007_s00415_024_12200_y crossref_primary_10_1016_j_techfore_2021_120775 crossref_primary_10_1016_j_parkreldis_2015_08_031 crossref_primary_10_3233_JPD_150549 crossref_primary_10_1016_j_yebeh_2021_107863 crossref_primary_10_4103_0028_3886_359193 crossref_primary_10_1016_j_jocn_2012_05_015 crossref_primary_10_23736_S1973_9087_23_07954_6 crossref_primary_10_3390_brainsci12121735 crossref_primary_10_1111_1460_6984_13024 crossref_primary_10_1093_milmed_usaa203 crossref_primary_10_1177_1941874412450714 crossref_primary_10_14802_jmd_20099 crossref_primary_10_1177_1941874412450716 crossref_primary_10_3389_fneur_2021_694872 crossref_primary_10_4103_0028_3886_329546 crossref_primary_10_1002_mds_26744 crossref_primary_10_1155_2022_2920255 crossref_primary_10_1089_tmj_2021_0117 |
| Cites_doi | 10.1002/mds.870090114 10.1002/mds.10011 10.1002/mds.22379 10.1002/mds.22498 10.1212/01.wnl.0000269671.08423.14 10.1212/01.WNL.0000068010.82167.CF 10.1111/j.1532-5415.1996.tb06408.x 10.1002/mds.20101 10.1111/j.1532-5415.2005.53221.x 10.1007/BF02260863 10.1136/bmj.303.6805.741 10.1111/j.1532-5415.2000.tb06891.x 10.1002/mds.870080326 10.4065/77.9.918 10.1258/135763306775321371 10.1258/jtt.2008.080901 10.1136/jnnp.69.1.67 10.1136/jnnp.2004.057984 10.1016/S1353-8020(02)00004-4 |
| ContentType | Journal Article |
| Copyright | Copyright © 2010 Movement Disorder Society 2015 INIST-CNRS |
| Copyright_xml | – notice: Copyright © 2010 Movement Disorder Society – notice: 2015 INIST-CNRS |
| DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1002/mds.23145 |
| DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1531-8257 |
| EndPage | 1659 |
| ExternalDocumentID | 20533449 23164119 10_1002_mds_23145 MDS23145 ark_67375_WNG_62J3M2VD_M |
| Genre | article Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1L6 1OB 1OC 1ZS 31~ 33P 3PY 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABIJN ABJNI ABLJU ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR1 DR2 DRFUL DRMAN DRSTM DU5 EBS EJD F00 F01 F04 F5P FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HGLYW HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K ROL RWD RWI RX1 RYL SUPJJ TEORI TWZ UB1 V2E V9Y W8V W99 WBKPD WHWMO WIB WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WXI WXSBR XG1 XV2 YCJ ZZTAW ~IA ~WT AAHQN AAIPD AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AFWVQ ALVPJ AAYXX AEYWJ AGQPQ AGYGG CITATION .GJ 1CY 53G AAMMB ABEML ACSCC AEFGJ AGHNM AGXDD AIDQK AIDYY EBD EMOBN FYBCS IQODW M6M PALCI RIWAO RJQFR SAMSI SV3 ZGI CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c4585-9567e23b5c144c4f42566ff98d321181260fd8c1fd9b4897b6e386f804c5b6ac3 |
| IEDL.DBID | DR2 |
| ISSN | 0885-3185 1531-8257 |
| IngestDate | Fri Jul 11 02:36:28 EDT 2025 Mon Jul 21 06:04:13 EDT 2025 Mon Jul 21 09:18:40 EDT 2025 Tue Jul 01 01:44:09 EDT 2025 Thu Apr 24 23:08:20 EDT 2025 Wed Jan 22 16:33:38 EST 2025 Wed Oct 30 09:54:10 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | Nervous system diseases Parkinson's disease Telemedicine Central nervous system disease Parkinson disease Degenerative disease clinical trials Care Cerebral disorder Extrapyramidal syndrome |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4585-9567e23b5c144c4f42566ff98d321181260fd8c1fd9b4897b6e386f804c5b6ac3 |
| Notes | ArticleID:MDS23145 Potential conflict of interest: Nothing to report. istex:B33692BC0EFC48AD2F2945FFD8F733C9ABA24FDC ark:/67375/WNG-62J3M2VD-M ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 |
| PMID | 20533449 |
| PQID | 748994257 |
| PQPubID | 23479 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_748994257 pubmed_primary_20533449 pascalfrancis_primary_23164119 crossref_citationtrail_10_1002_mds_23145 crossref_primary_10_1002_mds_23145 wiley_primary_10_1002_mds_23145_MDS23145 istex_primary_ark_67375_WNG_62J3M2VD_M |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 15 August 2010 |
| PublicationDateYYYYMMDD | 2010-08-15 |
| PublicationDate_xml | – month: 08 year: 2010 text: 15 August 2010 day: 15 |
| PublicationDecade | 2010 |
| PublicationPlace | Hoboken |
| PublicationPlace_xml | – name: Hoboken – name: Hoboken, NJ – name: United States |
| PublicationTitle | Movement disorders |
| PublicationTitleAlternate | Mov. Disord |
| PublicationYear | 2010 |
| Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley |
| Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley |
| References | Moreno-Ramirez D,Ferrandiz L,Ruiz-de-Cases A, et al. Economic evaluation of a store-and-forward teledermatology system for skin cancer patients. J Telemed Telecare 2009; 15: 40-45. Peto V,Jenkinson C,Fitzpatrick R,Greenhall R. The Development and validation of a short measure of functioning and well-being for individuals with Parkinson's disease. Qual Life Res 1995; 4: 241-248. Schrag A,Selai C,Jahanshahi M,Quinn NP. The EQ-5D-a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2000; 69: 67-73. Samii A,Ryan-Dykes P,Tsukuda RA,Zink C,Franks R,Nichol WP. Telemedicine for the delivery of health care in Parkinson's disease. J Telemed Telecare 2006; 12: 16-18. Biglan KM,Voss TS,Deuel LM, et al. Telemedicine for the care of nursing home residents with Parkinson disease. Mov Disord 2009; 24: 1073-1076. Mitchell SL,Kiely DK,Kiel DP,Lipsitz LA. The epidemiology, clinical characteristics, and natural history of older nursing home residents with a diagnosis of Parkinson's disease. J Am Geriatr Soc 1996; 44: 394-399. Hubble JP,Pahwa R,Michalek DK,Thomas C,Koller WC. Interactive video conferencing: a means of providing interim care to Parkinson's disease patients. Mov Disord 1993; 8: 380-382. Institute of Medicine: Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington DC: National Academy Press, 2001. Aarsland D,Larsen JP,Tandberg E,Laake K. Predictors of nursing home placements in Parkinson's disease: a population-based prospective study. J Am Geriatr Soc 2000; 48: 938-942. Buchanan RJ,Wang S,Huang C,Simpson P,Manyam BV. Analyses of nursing home residents with Parkinson's disease using the minimum data set. Parkinsonism Relat Disord 2002; 8: 369-380. Ertan FS,Ertan T,Kiziltan G,Uygucgil H. Reliability and validity of the Geriatric Depression Scale in Depression in Parkinson's disease. J Neurol Neurosurg Psychiatr 2005; 76: 1445-1447. Factor SA,Feustel PJ,Friedman JH, et al. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 2003; 60: 1756-1761. Goetz CG,Stebbins GT,Wolff D, et al. Testing objective measures of motor impairment in early Parkinson's disease: feasibility study of an at-home testing device. Mov Disord 2009; 24: 551-556. Verhagen Metman L,Myre B,Verwey N, et al. Test-retest reliability of UPDRS-III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: an argument against multiple baseline assessments. Mov Disord 2004; 19: 1079-1084. Larsen JP. The Norwegian Study Group of Parkinson's Disease in the Elderly. Parkinson's disease as community health problem: study in Norwegian nursing homes. Br Med J 1991; 303: 741-743. Nasreddine ZS,Phillips NA,Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699. Parashos SA,Maraganore DM,O'Briend PC,Rocca WA. Medical services utilization and prognosis in Parkinson disease: a population-based study. Mayo Clin Proc 2002; 77: 918-925. Bhanoo SN. Denmark leads the way in digital care. The New York Times; January 12, 2010, D5. Siderowf A,McDermott M,Kieburtz K,Blindauer K,Plumb S,Shoulson I, and the Parkinson Study Group. Test-retest reliability of the Unified Parkinson's Disease Rating Scale in Patients with Early Parkinson's Disease: results from a multicenter clinical trial. Mov Disord 2002; 17: 758-763. Davies AR,Ware JE. GHAA's Consumer Satisfaction Survey and User's Manual, Second ed. Washington DC: Group Health Association of America; 1991. Schwab S,Vatankhah B,Kukla C, et al. Long-term outcome after thrombolysis in telemedical stroke care. Neurology 2007; 69: 898-903. Richards M,Marder K,Cote L,Mayeux R. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination. Mov Disord 1994; 9: 89-91. 1994; 9 1993; 8 2002; 17 2009; 24 2006; 12 2000; 69 2001 2000; 48 2004; 19 2010 2002; 77 2002; 8 2009 2010; D5 2008 2005; 53 2005; 76 1991 2003; 60 1991; 303 1995; 4 2007; 69 2009; 15 1996; 44 e_1_2_7_5_2 e_1_2_7_4_2 e_1_2_7_3_2 e_1_2_7_2_2 e_1_2_7_9_2 e_1_2_7_8_2 e_1_2_7_7_2 e_1_2_7_6_2 e_1_2_7_19_2 e_1_2_7_18_2 e_1_2_7_17_2 e_1_2_7_16_2 e_1_2_7_14_2 e_1_2_7_13_2 e_1_2_7_12_2 e_1_2_7_11_2 Bhanoo SN (e_1_2_7_28_2) 2010; 5 e_1_2_7_26_2 e_1_2_7_27_2 e_1_2_7_25_2 e_1_2_7_24_2 e_1_2_7_23_2 Institute of Medicine: Committee on Quality of Health Care in America (e_1_2_7_15_2) 2001 e_1_2_7_22_2 e_1_2_7_21_2 e_1_2_7_20_2 Davies AR (e_1_2_7_10_2) 1991 |
| References_xml | – reference: Richards M,Marder K,Cote L,Mayeux R. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination. Mov Disord 1994; 9: 89-91. – reference: Schwab S,Vatankhah B,Kukla C, et al. Long-term outcome after thrombolysis in telemedical stroke care. Neurology 2007; 69: 898-903. – reference: Goetz CG,Stebbins GT,Wolff D, et al. Testing objective measures of motor impairment in early Parkinson's disease: feasibility study of an at-home testing device. Mov Disord 2009; 24: 551-556. – reference: Moreno-Ramirez D,Ferrandiz L,Ruiz-de-Cases A, et al. Economic evaluation of a store-and-forward teledermatology system for skin cancer patients. J Telemed Telecare 2009; 15: 40-45. – reference: Buchanan RJ,Wang S,Huang C,Simpson P,Manyam BV. Analyses of nursing home residents with Parkinson's disease using the minimum data set. Parkinsonism Relat Disord 2002; 8: 369-380. – reference: Hubble JP,Pahwa R,Michalek DK,Thomas C,Koller WC. Interactive video conferencing: a means of providing interim care to Parkinson's disease patients. Mov Disord 1993; 8: 380-382. – reference: Ertan FS,Ertan T,Kiziltan G,Uygucgil H. Reliability and validity of the Geriatric Depression Scale in Depression in Parkinson's disease. J Neurol Neurosurg Psychiatr 2005; 76: 1445-1447. – reference: Factor SA,Feustel PJ,Friedman JH, et al. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology 2003; 60: 1756-1761. – reference: Bhanoo SN. Denmark leads the way in digital care. The New York Times; January 12, 2010, D5. – reference: Biglan KM,Voss TS,Deuel LM, et al. Telemedicine for the care of nursing home residents with Parkinson disease. Mov Disord 2009; 24: 1073-1076. – reference: Nasreddine ZS,Phillips NA,Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699. – reference: Mitchell SL,Kiely DK,Kiel DP,Lipsitz LA. The epidemiology, clinical characteristics, and natural history of older nursing home residents with a diagnosis of Parkinson's disease. J Am Geriatr Soc 1996; 44: 394-399. – reference: Peto V,Jenkinson C,Fitzpatrick R,Greenhall R. The Development and validation of a short measure of functioning and well-being for individuals with Parkinson's disease. Qual Life Res 1995; 4: 241-248. – reference: Davies AR,Ware JE. GHAA's Consumer Satisfaction Survey and User's Manual, Second ed. Washington DC: Group Health Association of America; 1991. – reference: Institute of Medicine: Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington DC: National Academy Press, 2001. – reference: Parashos SA,Maraganore DM,O'Briend PC,Rocca WA. Medical services utilization and prognosis in Parkinson disease: a population-based study. Mayo Clin Proc 2002; 77: 918-925. – reference: Verhagen Metman L,Myre B,Verwey N, et al. Test-retest reliability of UPDRS-III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: an argument against multiple baseline assessments. Mov Disord 2004; 19: 1079-1084. – reference: Larsen JP. The Norwegian Study Group of Parkinson's Disease in the Elderly. Parkinson's disease as community health problem: study in Norwegian nursing homes. Br Med J 1991; 303: 741-743. – reference: Siderowf A,McDermott M,Kieburtz K,Blindauer K,Plumb S,Shoulson I, and the Parkinson Study Group. Test-retest reliability of the Unified Parkinson's Disease Rating Scale in Patients with Early Parkinson's Disease: results from a multicenter clinical trial. Mov Disord 2002; 17: 758-763. – reference: Aarsland D,Larsen JP,Tandberg E,Laake K. Predictors of nursing home placements in Parkinson's disease: a population-based prospective study. J Am Geriatr Soc 2000; 48: 938-942. – reference: Schrag A,Selai C,Jahanshahi M,Quinn NP. The EQ-5D-a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2000; 69: 67-73. – reference: Samii A,Ryan-Dykes P,Tsukuda RA,Zink C,Franks R,Nichol WP. Telemedicine for the delivery of health care in Parkinson's disease. J Telemed Telecare 2006; 12: 16-18. – volume: 24 start-page: 1073 year: 2009 end-page: 1076 article-title: Telemedicine for the care of nursing home residents with Parkinson disease publication-title: Mov Disord – volume: D5 year: 2010 article-title: Denmark leads the way in digital care publication-title: The New York Times – year: 2009 – volume: 60 start-page: 1756 year: 2003 end-page: 1761 article-title: Longitudinal outcome of Parkinson's disease patients with psychosis publication-title: Neurology – volume: 8 start-page: 369 year: 2002 end-page: 380 article-title: Analyses of nursing home residents with Parkinson's disease using the minimum data set publication-title: Parkinsonism Relat Disord – volume: 19 start-page: 1079 year: 2004 end-page: 1084 article-title: Test‐retest reliability of UPDRS‐III, dyskinesia scales, and timed motor tests in patients with advanced Parkinson's disease: an argument against multiple baseline assessments publication-title: Mov Disord – volume: 9 start-page: 89 year: 1994 end-page: 91 article-title: Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination publication-title: Mov Disord – volume: 4 start-page: 241 year: 1995 end-page: 248 article-title: The Development and validation of a short measure of functioning and well‐being for individuals with Parkinson's disease publication-title: Qual Life Res – volume: 77 start-page: 918 year: 2002 end-page: 925 article-title: Medical services utilization and prognosis in Parkinson disease: a population‐based study publication-title: Mayo Clin Proc – volume: 303 start-page: 741 year: 1991 end-page: 743 article-title: The Norwegian Study Group of Parkinson's Disease in the Elderly. Parkinson's disease as community health problem: study in Norwegian nursing homes publication-title: Br Med J – year: 2001 – volume: 69 start-page: 67 year: 2000 end-page: 73 article-title: The EQ‐5D–a generic quality of life measure–is a useful instrument to measure quality of life in patients with Parkinson's disease publication-title: J Neurol Neurosurg Psychiatry – volume: 8 start-page: 380 year: 1993 end-page: 382 article-title: Interactive video conferencing: a means of providing interim care to Parkinson's disease patients publication-title: Mov Disord – volume: 17 start-page: 758 year: 2002 end-page: 763 article-title: Test‐retest reliability of the Unified Parkinson's Disease Rating Scale in Patients with Early Parkinson's Disease: results from a multicenter clinical trial publication-title: Mov Disord – year: 2010 – volume: 24 start-page: 551 year: 2009 end-page: 556 article-title: Testing objective measures of motor impairment in early Parkinson's disease: feasibility study of an at‐home testing device publication-title: Mov Disord – volume: 44 start-page: 394 year: 1996 end-page: 399 article-title: The epidemiology, clinical characteristics, and natural history of older nursing home residents with a diagnosis of Parkinson's disease publication-title: J Am Geriatr Soc – volume: 12 start-page: 16 year: 2006 end-page: 18 article-title: Telemedicine for the delivery of health care in Parkinson's disease publication-title: J Telemed Telecare – year: 2008 – volume: 69 start-page: 898 year: 2007 end-page: 903 article-title: Long‐term outcome after thrombolysis in telemedical stroke care publication-title: Neurology – volume: 53 start-page: 695 year: 2005 end-page: 699 article-title: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment publication-title: J Am Geriatr Soc – volume: 76 start-page: 1445 year: 2005 end-page: 1447 article-title: Reliability and validity of the Geriatric Depression Scale in Depression in Parkinson's disease publication-title: J Neurol Neurosurg Psychiatr – volume: 48 start-page: 938 year: 2000 end-page: 942 article-title: Predictors of nursing home placements in Parkinson's disease: a population‐based prospective study publication-title: J Am Geriatr Soc – volume: 15 start-page: 40 year: 2009 end-page: 45 article-title: Economic evaluation of a store‐and‐forward teledermatology system for skin cancer patients publication-title: J Telemed Telecare – year: 1991 – ident: e_1_2_7_11_2 doi: 10.1002/mds.870090114 – ident: e_1_2_7_14_2 doi: 10.1002/mds.10011 – ident: e_1_2_7_16_2 doi: 10.1002/mds.22379 – ident: e_1_2_7_6_2 doi: 10.1002/mds.22498 – ident: e_1_2_7_24_2 – ident: e_1_2_7_27_2 – ident: e_1_2_7_2_2 doi: 10.1212/01.wnl.0000269671.08423.14 – volume-title: Crossing the Quality Chasm: A New Health System for the 21st Century year: 2001 ident: e_1_2_7_15_2 – ident: e_1_2_7_18_2 doi: 10.1212/01.WNL.0000068010.82167.CF – ident: e_1_2_7_26_2 – ident: e_1_2_7_22_2 doi: 10.1111/j.1532-5415.1996.tb06408.x – ident: e_1_2_7_23_2 doi: 10.1002/mds.20101 – ident: e_1_2_7_13_2 doi: 10.1111/j.1532-5415.2005.53221.x – ident: e_1_2_7_8_2 doi: 10.1007/BF02260863 – ident: e_1_2_7_7_2 doi: 10.1136/bmj.303.6805.741 – ident: e_1_2_7_19_2 doi: 10.1111/j.1532-5415.2000.tb06891.x – ident: e_1_2_7_4_2 doi: 10.1002/mds.870080326 – ident: e_1_2_7_20_2 doi: 10.4065/77.9.918 – ident: e_1_2_7_25_2 – volume-title: GHAA's Consumer Satisfaction Survey and User's Manual year: 1991 ident: e_1_2_7_10_2 – ident: e_1_2_7_5_2 doi: 10.1258/135763306775321371 – ident: e_1_2_7_3_2 doi: 10.1258/jtt.2008.080901 – ident: e_1_2_7_17_2 – ident: e_1_2_7_9_2 doi: 10.1136/jnnp.69.1.67 – volume: 5 year: 2010 ident: e_1_2_7_28_2 article-title: Denmark leads the way in digital care publication-title: The New York Times – ident: e_1_2_7_12_2 doi: 10.1136/jnnp.2004.057984 – ident: e_1_2_7_21_2 doi: 10.1016/S1353-8020(02)00004-4 |
| SSID | ssj0011516 |
| Score | 2.389556 |
| Snippet | We conducted a randomized, controlled pilot trial to evaluate the feasibility of providing subspecialty care via telemedicine for patients with Parkinson's... |
| SourceID | proquest pubmed pascalfrancis crossref wiley istex |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1652 |
| SubjectTerms | Aged Aged, 80 and over Biological and medical sciences clinical trials Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases Delivery of Health Care - methods Feasibility Studies Female Humans Internet Male Medical sciences Neurology Parkinson Disease - psychology Parkinson Disease - therapy Parkinson's disease Patient Satisfaction Pilot Projects Quality of Life Statistics, Nonparametric Surveys and Questionnaires telemedicine Telemedicine - methods Treatment Outcome |
| Title | Increasing access to specialty care: A pilot, randomized controlled trial of telemedicine for Parkinson's disease |
| URI | https://api.istex.fr/ark:/67375/WNG-62J3M2VD-M/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmds.23145 https://www.ncbi.nlm.nih.gov/pubmed/20533449 https://www.proquest.com/docview/748994257 |
| Volume | 25 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIiEuQHk1FCoLIeiBbBPHcRJ6qiilqrQ9AIUekKz4JVVsN6XJSm1_PTN2kmpRkRC3HOxo7czj8_qbbwh5nWCSVkLHdaJ1DBmPxXWWprFSOaszVxSF82qfR-LgmB-e5CcrZGeohQn6EOMfbugZPl6jg9eq3b4RDT0z7QTACccCc-RqISD6PEpHAdDxbU_BiXJfITyoCiVse5y5lIvu4LZeIjeybmF7XOhrcRvwXMaxPhHtPyA_hiUE_snPyaJTE339h7rjf67xIbnfA1S6GyxqjazY-SNyd9pfwT8mvyCiIJEdUh6tfbdF2jW0DW3suyuKVLL3dJeen86a7h2F9Znm7PTaGtqz4mfw6HuF0MbRziJ9PbybAn6mWIXtC9LetrS_PHpCjvc_fv1wEPd9G2LN4fQRw5GrsCxTuYbTmuYOwoIQzlWlyRjWucIRyplSp85UipdVoYTNSuHKhOtciVpnT8nqvJnbdUKFMYAwuIXQYbgWSWXKNHGQT5Vj2hRZRLaGLyh1L2qOvTVmMsgxMwlbKP0WRuTVOPQ8KHncNuiNN4NxBCwaqW9FLr8ffZKCHWZT9m1PTiOyuWQn4wR4jeBpWkWEDoYjwWPxGqae22bRStT7qTBURuRZMKibyb4ymsPkLW8Wf_-hcrr3xT88__ehG-Re4D6UcZq_IKvdxcK-BEjVqU3vO78BzMsa-g |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VVoJeKO-GR7EQgh7INg_HSRCXilKW0uwBWugFWbEdSxXbTSFZqe2v79hOUi0qEuLmw9iKnXnaM98AvAyMkRZM-mUgpY8WL_LLOAx9IZKojHWaptqifU7Y-JDuHSVHS_Cur4Vx-BDDhZuRDKuvjYCbC-mtK9TQE9WM0DuhyQ1YMR29bUD1ZQCPQlfHNj5FMUpsjXCPKxREW8PUBWu0Yg72zGRHlg0ekHadLa5zPRc9WWuKdtfgR78Jl4HyczRvxUhe_IHv-L-7vAO3Ox-VbDumugtL1ewe3Cy6V_j78AuVisllR6tHSttwkbQ1aVwn-_acmGyyt2SbnB5P6_YNwQ2q-uT4olKkS4yf4tC2CyG1Jm1lMtjd2gRdaGIKsW1N2uuGdO9HD-Bw98PB-7HftW7wJcUAxMeoK62iWCQSAzZJNWoGxrTOMxVHptQVoyitMhlqlQua5algVZwxnQVUJoKVMn4Iy7N6Vq0DYUqhk0Er1B6KShbkKgsDjSZV6EiqNPZgs_-FXHa45qa9xpQ7ROaI4xFye4QevBhITx2Yx3VErywfDBS4aZP9lib8--QjZ9FeXETfdnjhwcYCowwTcBlGwzD3gPScw1FozUtMOavqecMN5E9utKUHjxxHXU22xdEUJ29avvj7h_Ji56sdPP530udwa3xQ7PP9T5PPT2DVpUJkfpg8heX297x6hh5WKzasIF0CZhkfFQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VVqq4lPIOhWIhBD2QbR6Ok8CpYllKYVcIaOkByYrtWKq63WxJVir99YztJNWiIiFuOYytjDPPeOYbgOeBcdKCSb8IpPTR40V-EYehL0QSFbFO01RbtM8J2z-kB8fJ8Qq86XphHD5E_8PNaIa110bB50rvXoGGnql6gMEJTW7AGmVBZkR6-KXHjsJIx849RS1KbItwBysURLv90iVntGbO9cIURxY1no92gy2uizyXA1nriUa34EfHgytAOR0sGjGQl3_AO_4nk5uw0UaoZM-J1G1YKWd3YH3c3sHfhXM0KaaSHX0eKey4RdJUpHZz7JtfxNSSvSZ7ZH4yrZpXBPlT1dnJZalIWxY_xUc7LIRUmjSlqV93exMMoIlpw7YdaS9r0t4e3YPD0btvb_f9dnCDLymmHz7mXGkZxSKRmK5JqtEuMKZ1nqk4Mo2umENplclQq1zQLE8FK-OM6SygMhGskPF9WJ1Vs_IhEKYUhhi0RNuhqGRBrrIw0OhQhY6kSmMPdrovyGWLam6Ga0y5w2OOOB4ht0fowbOedO6gPK4jemHFoKdApk3tW5rw75P3nEUH8Tg6GvKxB9tLctIvwG0YDcPcA9IJDkeVNfcwxaysFjU3gD-5sZUePHACdbXYtkZTXLxjxeLvL8rHw6_24dG_kz6F9c_DEf_0YfJxC266OojMD5PHsNr8XJRPMLxqxLZVo98RQx3N |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Increasing+Access+to+Specialty+Care%3A+A+Pilot%2C+Randomized+Controlled+Trial+of+Telemedicine+for+Parkinson%27s+Disease&rft.jtitle=Movement+disorders&rft.au=DORSEY%2C+E.+Ray&rft.au=DEUEL%2C+Lisa+M&rft.au=VITI%2C+Lucy&rft.au=SMITH%2C+Sandy&rft.date=2010-08-15&rft.pub=Wiley&rft.issn=0885-3185&rft.volume=25&rft.issue=11&rft.spage=1652&rft.epage=1659&rft_id=info:doi/10.1002%2Fmds.23145&rft.externalDBID=n%2Fa&rft.externalDocID=23164119 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0885-3185&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0885-3185&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0885-3185&client=summon |